[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583971":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":41,"responsibleParty":59,"collaborators":26,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":26,"maxAge":26,"enrollmentInfo":70,"targetDuration":26,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Sanford Health","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental Group","EXPERIMENTAL","The experimental group will receive 2mA of anodal transcranial direct current stimulation (tDCS) for 20 minutes daily for 5 consecutive days.",[13],"Device: transcranial direct current stimulation (tDCS)",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham Group","SHAM_COMPARATOR","The sham group will be connected to the anodal transcranial direct current stimulation device daily for 5 days. During the 20 minute sessions, the participant will only receive stimulation for a 30-second ramp up period, at which point the stimulation will be discontinued for the remainder of the time.",[19],"Device: Sham (No Treatment)",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","transcranial direct current stimulation (tDCS)","2 mA will be administered for 5 consecutive days for a duration of 20 minutes with electrode placement at the left dorsolateral prefrontal cortex.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Sham (No Treatment)","For 30 seconds, the patient will experience a ramp up of the stimulation, after which point no stimulation will be transmitted for the remainder of the session. This will be administered for 5 consecutive days for a duration of 20 minutes with electrode placement at the left dorsolateral prefrontal cortex",[15],[32],{"name":33,"affiliation":5,"role":34},"Jau-Shin Lou, MD","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},"Jessica Keller, B.S.","CONTACT","701-417-5781","jessica.keller@sanfordhealth.org",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Sanford Brain and Spine Center","RECRUITING","Fargo","North Dakota","58103","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-96.7898,46.87719,{"lat":54,"lon":53},[57,58],{"name":37,"role":38,"phone":39,"phoneExt":26,"email":40},{"name":33,"role":34,"phone":26,"phoneExt":26,"email":26},{"type":60,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100583971","transcranial-direct-current-stimulation-for-motor-function-and-fatigue-in-pd-100583971",false,"NCT06883266","Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD","Transcranial Direct Current Stimulation (tDCS) to Improve Motor Function and Motor Fatigue in Parkinson's Patients","tDCS","Inclusion Criteria:\n\n* Clinical diagnosis of PD with at least two of the four diagnostic criteria for PD (tremor, rigidity, bradykinesia, and postural instability)\n* Must be able to consent\n\nExclusion Criteria:\n\n* Patients with dementia (MOCA \\\u003C 21)\n* PD treatment using deep brain stimulation (DBS)\n* Diagnosis of psychosis\n* Diagnosis of multiple sclerosis\n* Diagnosis of stroke\n* Diagnosis of chronic obstructive pulmonary disease (COPD)\n* Diagnosis of congestive heart failure (CHF)","ALL",{"count":71,"type":72},64,"ESTIMATED","INTERVENTIONAL",[75],"NA","The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.",[78],"Parkinsons Disease (PD)",[80,67,81,82],"Parkinsons Disease","Motor Function","Motor Fatigue","2026-01-30",{"date":85,"type":86},"2026-02-03","ACTUAL",{"date":88,"type":86},"2024-11-11",{"date":90,"type":72},"2026-12-11",{"name":5,"class":6},1]